Adyen leads structurally, with profitability as the clearest single gap between the two profiles. Pfizer still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Pfizer, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Adyen, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (ADYEN.AS: STOXX 600, PFE: Russell 1000).
Profitability still does most of the heavy lifting in this comparison. Adyen N.V. leads by 9 points on the overall comparison score.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair still fits the compare framework, though the long-term structural overlap is relatively light.
Most of the shared profile comes through capital structure and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Adyen N.V. is stronger, but the price setup still looks more supportive for Pfizer Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where ADYEN.AS and PFE each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 17.9-point operating margin advantage.
Absolute pricing still looks more supportive for Pfizer, with a forward P/E that is 9.9 turns lower there.
The profitability lead is clear, but pricing and valuation still pull in the other direction — the result holds, but not without friction.
Break down the ADYEN.AS vs PFE comparison across all dimensions with the full interactive tool.
Explore how ADYEN.AS and PFE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.